Status:
UNKNOWN
Lidocaine Infusion On Hysteroscopic Media Versus Oral Diclofinac For Pain Relief During Outpatient Hysteroscopy
Lead Sponsor:
Ain Shams University
Conditions:
Nulliparity
Eligibility:
FEMALE
18-35 years
Phase:
NA
Brief Summary
Lidocaine Infusion On Hysteroscopic Media Versus Oral Diclofinac For Pain Relief During Outpatient Hysteroscopy. A Randomized Controlled Trial.
Detailed Description
10 ml of 2% lidocaine hydrochloride added on saline infusion media versus 100 mg diclofenac tablet 1 hour before office hysteroscopy , to test their efficacy in reducing pain .
Eligibility Criteria
Inclusion
- Age: 18-35 years.
- BMI 18.5-30 Kg.
- Nulliparous women assigned for diagnostic hysteroscopy.
- Informed written consent.
Exclusion
- Previous cervical surgery.
- Cervical stenosis.
- Known gastritis.
- Recent or active PID.
- Cardiac patients.
Key Trial Info
Start Date :
October 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2018
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT03298646
Start Date
October 1 2017
End Date
January 1 2018
Last Update
October 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams maternity hospital
Cairo, Egypt